Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleoporin 35 pseudogene 1 (NUP35P1) is classified as a pseudogene, meaning it is a segment of DNA that resembles the functional gene NUP35 but does not encode a functional protein product due to mutations or deletions that prevent normal gene expression. NUP35P1 is not considered a coding or functional gene, nor is it a recognized therapeutic target such as a receptor, enzyme, or transporter. It is primarily annotated for genomic reference and does not have established roles in known biological functions, diseases, or drug interactions[5].\n\nAdditional context: \n- Pseudogenes like NUP35P1 are generally not transcribed into functional proteins and thus do not serve as drug targets or have mechanisms of action associated with therapeutic intervention.\n- The functional gene closely related to this pseudogene is NUP35, which encodes a nucleoporin protein involved in the nuclear pore complex, but NUP35P1 does not share this function[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleoporin 35 pseudogene 1 (NUP35P1).